New patent for AKORN drug ZIOPTAN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ZIOPTAN
Annual Drug Patent Expirations for ZIOPTAN

Zioptan is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

ZIOPTAN drug price trends.

Drug patent litigation for ZIOPTAN.

This drug has sixty-eight patent family members in thirty-one countries.

The generic ingredient in ZIOPTAN is tafluprost. One supplier is listed for this compound. Additional details are available on the tafluprost profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top